CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
CRISPR Therapeutics shows promise in gene therapy with its groundbreaking treatments for genetic diseases. Despite challenges like establishing treatment centers and gaining long-term data, the company's leadership in gene editing positions it well for future success.